800
Participants
Start Date
May 29, 2005
Primary Completion Date
March 16, 2008
Study Completion Date
July 17, 2015
Nitric oxide
Nitric Oxide vapour (gas) for inhalation (400 ppm)
Placebo
Placebo gas for inhalation
Campus Charite Mitte, Berlin
Ospedali Riuniti, Bergamo
Hospital Universitario Gregorio Mar, Madrid
Hosspital Univeritario La Paz, Madrid
Universitaetsklinikum Marburg, Marburg
University Padova, Padua
Hospital Universitario Canarias, Santa Cruz de Tenerife
Policlinico S. Orsola, Bologna
Hospital Universitario Virgen del Rocio, Seville
Hospital Mere-Enfant, Nantes
Hospital Universitario La Fe, Valencia
Hospital de Cruces, Barakaldo
Azienda Ospedaliera Careggi, Florence
Az. Osp. G. Salesi, Ancona
Universitaetsklinikum Mannheim, Mannheim
Universitaetsklinikum Heidelberg, Heidelberg
Universitaeklinikum Tuebingen, Tübingen
Hospital Robert Debre, Paris
Universitaetsklinikum Muenchen, München
Univeritaetsklinik Ulm, Ulm
Centre Hospitalier Intercommunal de Creteil, Créteil
UCL St. LUC, Brussels
Clinique Notre Dame, Charleroi
Universitair Ziekenhuis Antwerpen, Edegem
Clinique St. Vincent CHC, Rocourt
Oulun yliopsistollinen sairaala, Oulu
Policlinico Gemelli, Roma
Beatrix Children's Hospital, University Medical Center Groningen, Groningen
Sophia Kinderziekenhuis, Rotterdam
Hospital Universitario Vall d'Hebron, Barcelona
Astrid Lindgrens barnsjukjus, Karolinska Unviersritets sjukhuset-Solna, Stockholm
Akademiska Sjukhuset, Uppsala
Meedway Mariton Hospital, Gillingham
Leicester Royal Infirmary, Leicester
Kings College, London
Lead Sponsor
Mallinckrodt
INDUSTRY